Veterinary Medicines Directorate seeks senior assessor for quality review work
The UK Veterinary Medicines Directorate has opened recruitment for a Senior Pharmaceutical Quality Assessor, a Grade G7 post within the Quality team of the Pharmaceuticals Section. The vacancy sits inside the Authorisations Division and is centered on one of the most technical parts of veterinary medicines regulation: judging whether the quality data submitted by companies is robust enough to support marketing authorisations and later variations to those authorisations.
The post is not an administrative placeholder. It is a regulatory science role with direct consequences for the medicines that reach veterinary practice, the standards applied to manufacturers, and the consistency of the evidence used in authorization decisions. Quality assessment is the point where product development meets regulatory scrutiny. If the dossier is incomplete or analytically weak, the decision-making process becomes more difficult; if the evidence is strong, the route to authorisation is cleaner and more defensible.
The advertised salary is £64,015 per annum with pension scheme, and annual leave begins at 25 days. Applications must be submitted through Civil Service Jobs, and the closing date is 14 December 2026.
Quality assessment sits at the center of veterinary medicine regulation
Within the VMD structure, the Quality team is described as one of three specialist teams in the Pharmaceuticals Section. Its primary function is to assess quality data that companies submit in support of applications for marketing authorisations for veterinary medicines, along with applications to vary existing authorisations. In regulatory terms, quality is not a narrow laboratory concern; it is a broad assessment of whether a product can be manufactured consistently, characterized reliably, and controlled appropriately over time.
This matters because veterinary medicines are used across species, formulations, and treatment settings that can place unusual demands on the dossier. A solid quality package helps regulators judge product identity, purity, stability, and manufacturing consistency. The assessor’s work therefore acts as a gatekeeper function between commercial development and public confidence in the veterinary supply chain.
A senior assessor is expected to do more than read technical files. The role implies judgment, regulatory interpretation, and the ability to apply scientific standards in a way that can stand up to challenge from industry, colleagues, and international counterparts. In practice, this kind of work demands fluency in pharmaceutical quality systems, an eye for detail, and the ability to connect dossier evidence with the legal framework governing authorisation.
Regulatory science now extends beyond individual dossiers
The vacancy description places unusual emphasis on broader regulatory science responsibilities. The Quality team also contributes to the VMD’s regulatory science strategy, helps develop regulatory and scientific guidelines for the pharmaceutical industry, and supports international activity, including training other veterinary medicine regulators.
Those responsibilities point to a role that reaches well beyond case-by-case assessment. Guideline development shapes how companies prepare submissions before an application is even filed. International training, in turn, can harmonize expectations across jurisdictions and improve the consistency of review standards. In a field where product quality affects animal health, food-producing systems, and prescribing confidence, uniformity of assessment is not a bureaucratic luxury; it is part of the safety net.
The mention of international activities also suggests that the post has a policy and capacity-building dimension. Senior assessors often become the people who translate regulatory principles into workable expectations for applicants and partner agencies. When that happens well, companies spend less time guessing what a regulator wants and more time aligning development plans with clearly defined standards.
A vacancy like this also signals the continuing need for specialist expertise in public-sector medicines regulation. Quality assessment requires a blend of technical pharmacology, manufacturing knowledge, and regulatory judgment that is not easily replaced by generalist experience. The role draws on a very specific skill set, and the ad makes clear that the VMD is looking for someone who can contribute at that level.
What the post implies for applicants and for veterinary regulation
The structure of the announcement is straightforward, but the job itself is anything but routine. A senior assessor working on veterinary medicine authorisations is likely to deal with detailed data packages and may need to support complex decisions around variations to existing approvals. Those decisions can affect how a product is manufactured, controlled, or described in approved documentation, all of which have downstream implications for clinicians and producers who rely on the medicine.
Because the Quality team is embedded in authorisations rather than operating in isolation, the post likely requires close coordination with other specialists inside the division. The assessment of quality data rarely sits alone; it interacts with broader considerations of regulatory compliance, product lifecycle management, and scientific guidance. The seniority attached to a Grade G7 role suggests that the post holder will be expected to work with a high degree of autonomy while contributing to team standards and wider departmental objectives.
The recruitment notice gives only the essentials, but those essentials are revealing. The VMD is filling a position that links technical evaluation with regulatory strategy, and the successful applicant will sit at a point where science, policy, and practical authorisation work intersect. For professionals with experience in pharmaceutical quality assessment and an interest in veterinary medicines, the post offers a route into a regulatory role with both operational and strategic weight.
Application details and deadline
Applicants must use the Civil Service Jobs listing for the Senior Pharmaceutical Quality Assessor role, where the full job description is available. The closing date is 14 December 2026.
No further clinical data, trial results, or product safety findings are attached to the notice. The public record here is a recruitment announcement, not a regulatory assessment or scientific opinion. The practical takeaway is narrower: the VMD is seeking specialist expertise to support the quality review of veterinary medicine authorisations, and the deadline for applications is fixed.